Verified Clinical Trials y Chubb anuncian una alianza estratégica

Hospitals Face Mounting Margin Pressure as Reactive Revenue Cycles Put Financial Stability at Risk

Kevin Kuykendall Launches Scholarship to Cultivate Next Generation of Entrepreneurial Leaders in Business and Healthcare

Ember LifeSciences introduces Ember Cube 2, earns 'Best of the Best' Red Dot Design Award

Shareholder Alert: Ademi LLP investigates whether KalVista Pharmaceuticals Inc. is obtaining a Fair Price for Public Shareholders

Immune Cells Rewire Themselves to Keep Battling Tumors in Nutrient Poor Environments

Summer Job Search Is Peaking Earlier Than Usual - OysterLink

Arizona College of Nursing Celebrates April 2026 Graduates Across 17 U.S. Campuses

SportsMed Physical Therapy Wins Two Stevie® Awards in the 24th Annual American Business Awards®

Food Colors Market Projected to Garner $7.8 Billion by 2032, at a CAGR of 13.2%: Allied Market Research

Re:Cognition Health Achieves Global Clinical Site Assessment Recertification at its U.S. Clinics

Global Light Therapy Market Size Will Reach $802.7 Million by 2031, Growing at a CAGR of 4.4% -- Allied Market Research

Animal Rescue Corps partners with National Mill Dog Rescue to save more than 60 dogs from commercial breeders

BCEN Announces 2026 Distinguished Awards Honoring Top Board-Certified Emergency, Trauma, Transport and Burn Nurses

LiveOnNY Hosts Inaugural Luminaries & Legacies Celebration Honoring NYC Metro-Area Hospitals and Renowned Surgeon and Humanitarian Dr. Robert Montgomery

Thousands of attendees raise nearly $2 million for The Michael J. Fox Foundation at the 2026 Parkinson's Unity Walk

Healthcare Information Exchange Market worth $3.40 billion by 2031 | MarketsandMarkets™

AssureCare and Pillr Health Partner to Help Health Systems Tackle Specialty Pharmacy Costs

Purina Cat Chow Brings the Healing Power of Cats to College Campuses Across the Country

Norgine gibt die Marktzulassung der Europäischen Kommission für XOLREMDI® (Mavorixafor) bekannt, die erste zugelassene Behandlung für Patienten mit WHIM-Syndrom in der Europäischen Union

SnapCare and connectRN Join Forces to Provide Growth-Forward Workforce Solutions Powering Better Care

RED PHONE BOOTH HOSTS NATIONWIDE KENTUCKY DERBY WATCH PARTY ON MAY 2

GreenTree Hospitality Group Ltd. Reports Fourth Quarter and Fiscal Year 2025 Financial Results

Expression Therapeutics Receives FDA Fast Track and Rare Pediatric Disease Designations for Investigational Stem Cell Therapy for Hemophilia A

What If Food Was at the Center of How We Live? Introducing CERES Chatt Hills - The Country's First Culinary Centric Community

NanoMosaic to Showcase the FDA/CBER AMT Designated Analytics Platform at ASGCT 2026

Earflo Announces FDA Clearance and US Market Availability of Award-Winning Pediatric Ear Pressure Treatment

Norgine announces European Commission Marketing Authorisation for XOLREMDI® (mavorixafor), the first authorised treatment for patients with WHIM syndrome in the European Union

R3 Continuum Expands Clinical Leadership Team to Accelerate Growth and Market Impact

NextPlat Expects Q1 2026 Gross Margins to Jump to 34+%, Operating Expenses to Decline 8+% From Q4 2025 and Achieve Positive Operating Income in Q3